Page 22 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

doi: 10.1002/cncr.33181 molecular fingerprinting in diagnosis and monitoring:
Validating volatile promises. Trends Mol Med.
90. Chotel F, Unnithan A, Chandrasekar CR, Parot R, Jeys L,
Grimer RJ. Variability in the presentation of synovial 2015;21(10):633-644.
sarcoma in children: A plea for greater awareness. J Bone doi: 10.1016/j.molmed.2015.08.001
Joint Surg Br. 2008;90(8):1090-1096. 101. Angioli R, Santonico M, Pennazza G, et al. Use of sensor
doi: 10.1302/0301-620X.90B8.19815 array analysis to detect ovarian cancer through breath,
urine, and blood: A case-control study. Diagnostics (Basel).
91. Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors 2024;14:561.
for patients with localized soft-tissue sarcoma treated with
conservation surgery and radiation therapy: An analysis of doi: 10.3390/diagnostics14050561
1225 patients. Cancer. 2003;97(10):2530-2543. 102. Rodriguez-Miguelez JM, Moreno-Ortega AJ, Sanz-
doi: 10.1002/cncr.11365 Melde A, et al. Inflammation-related biomarkers in
exhaled breath condensate for breast cancer diagnosis.
92. Acem I, van Praag VM, Mostert CQ, et al. Noninvasive Biosensors. 2020;10(5):46.
detection of soft tissue sarcoma using volatile organic
compounds in exhaled breath: A pilot study. Future Oncol. 103. Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A.
2023;19(10):697-704. Assessment, origin, and implementation of breath volatile
cancer markers. Chem Soc Rev. 2014;43(5):1423-1449.
doi: 10.2217/fon-2022-1122
doi: 10.1039/c3cs60329f
93. Wang XR, Cassells J, Berna AZ. Stability control for breath
analysis using GC-MS. J Chromatogr B Analyt Technol 104. Dragonieri S, Annema JT, Schot R, et al. An electronic nose
Biomed Life Sci. 2008;1097-1098:27-34. in the discrimination of patients with non-small cell lung
cancer and COPD. Lung Cancer. 2009;64(2):166-170.
doi: 10.1016/j.jchromb.2018.08.024
doi: 10.1016/j.lungcan.2008.08.008
94. Mathew TL, Pownraj P, Abdulla S, Pullithadathil B.
Technologies for clinical diagnosis using expired human 105. Ge P, Luo Y, Chen H, et al. Application of mass spectrometry
breath analysis. Diagnostics (Basel). 2015;5(1):27-60. in pancreatic cancer translational research. Front Oncol.
2021;11:667427.
doi: 10.3390/diagnostics5010027
doi: 10.3389/fonc.2021.667427
95. Steenhuis EGM, Schoenaker IJH, de Groot JWB, et al.
Feasibility of volatile organic compound in breath analysis 106. Raspagliesi F, Bogani G, Benedetti S, Grassi S, Ferla S,
in the follow-up of colorectal cancer: A pilot study. Eur J Buratti S. Detection of ovarian cancer through exhaled
Surg Oncol. 2020;46(11):2068-2073. breath by electronic nose: A prospective study. Cancers
(Basel). 2020;12(9):2408.
doi: 10.1016/j.ejso.2020.07.028
doi: 10.3390/cancers12092408
96. Fielding D, Davis M, Brown M, et al. VOC breath testing in
squamous cell carcinoma (SCC) of lung and larynx shows 107. Song C, Guo S, Jin S, Chen L, Jung YM. Biomarkers
distinct profiles each of which relate to tumour burden. determination based on surface-enhanced raman
J Thorac Oncol. 2015;10(9):S736-S736. scattering. Chemosensors. 2020;8(4):118.
97. Markar SR, Chin ST, Romano A, et al. Breath volatile organic doi: 10.3390/chemosensors8040118
compound profiling of colorectal cancer using selected ion 108. Chang JE, Lee DS, Ban SW, et al. Analysis of volatile
flow-tube mass spectrometry. Ann Surg. 2017;269:903-910. organic compounds in exhaled breath for lung cancer
doi: 10.1097/SLA.0000000000002539 diagnosis using a sensor system. Sensors Actuators B Chem.
2018;255:800-807.
98. American Thoracic Society, European Respiratory Society.
ATS/ERS recommendations for standardized procedures doi: 10.1016/j.snb
for the online and offline measurement of exhaled lower 109. Kumar S, Chauhan D, Renugopalakrishnan V, Malhotra
respiratory nitric oxide and nasal nitric oxide, 2005. Am J BD. Biofunctionalized nanodot zirconia-based efficient
Respir Crit Care Med. 2005;171(8):912-930. biosensing platform for noninvasive oral cancer detection.
doi: 10.1164/rccm.200406-710ST MRS Communications. 2020;10:652-659.
99. Nidheesh VR, Mohapatra AK, Unnikrishnan VK, et al. doi: 10.1557/mrc.2020.75
Breath analysis for the screening and diagnosis of diseases. 110. Mazzone PJ. Exhaled breath volatile organic compound
Appl Spectrosc Rev. 2020;56(8-10):702-732. biomarkers in lung cancer. J Breath Res. 2012;6(2):027106.
doi: 10.1080/05704928.2020.1848857 doi: 10.1088/1752-7155/6/2/027106
100. Boots AW, Bos LD, van der Schee MP, et al. Exhaled 111. Grocki P, Woollam M, Wang L, et al. Chemometric analysis

Volume 3 Issue 2 (2024) 16 doi: 10.36922/td.2061